Novel reaction to new cystic fibrosis medication Trikafta

We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginni...

Descripción completa

Detalles Bibliográficos
Autores principales: Stashower, Julian, Carr, Patrick, Miller, Virginia, Zlotoff, Barrett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122137/
https://www.ncbi.nlm.nih.gov/pubmed/34026156
http://dx.doi.org/10.1002/ccr3.4116
_version_ 1783692523520131072
author Stashower, Julian
Carr, Patrick
Miller, Virginia
Zlotoff, Barrett
author_facet Stashower, Julian
Carr, Patrick
Miller, Virginia
Zlotoff, Barrett
author_sort Stashower, Julian
collection PubMed
description We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.
format Online
Article
Text
id pubmed-8122137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81221372021-05-21 Novel reaction to new cystic fibrosis medication Trikafta Stashower, Julian Carr, Patrick Miller, Virginia Zlotoff, Barrett Clin Case Rep Case Reports We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta. John Wiley and Sons Inc. 2021-05-04 /pmc/articles/PMC8122137/ /pubmed/34026156 http://dx.doi.org/10.1002/ccr3.4116 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Stashower, Julian
Carr, Patrick
Miller, Virginia
Zlotoff, Barrett
Novel reaction to new cystic fibrosis medication Trikafta
title Novel reaction to new cystic fibrosis medication Trikafta
title_full Novel reaction to new cystic fibrosis medication Trikafta
title_fullStr Novel reaction to new cystic fibrosis medication Trikafta
title_full_unstemmed Novel reaction to new cystic fibrosis medication Trikafta
title_short Novel reaction to new cystic fibrosis medication Trikafta
title_sort novel reaction to new cystic fibrosis medication trikafta
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122137/
https://www.ncbi.nlm.nih.gov/pubmed/34026156
http://dx.doi.org/10.1002/ccr3.4116
work_keys_str_mv AT stashowerjulian novelreactiontonewcysticfibrosismedicationtrikafta
AT carrpatrick novelreactiontonewcysticfibrosismedicationtrikafta
AT millervirginia novelreactiontonewcysticfibrosismedicationtrikafta
AT zlotoffbarrett novelreactiontonewcysticfibrosismedicationtrikafta

Ejemplares similares